Education
About Us
Working with TipRanks
Follow Us
Fonar Corp (FONR)
NASDAQ:FONR
FONR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$12.00 - $18.64
Previous CloseN/A
Volume3.43K
Average Volume (3M)27.64K
Market Cap
$102.35M
Enterprise Value$139.05M
Total Cash (Recent Filing)$54.38M
Total Debt (Recent Filing)$39.79M
Price to Earnings (P/E)13.3
Beta0.50
Next Earnings
Sep 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.37
Shares Outstanding6,203,465
10 Day Avg. Volume41,867
30 Day Avg. Volume27,635
Financial Highlights & Ratios
PEG Ratio-0.61
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio12.31
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue0.39
Enterprise Value/Gross Profit5.06
Enterprise Value/Ebitda1.51
Forecast
1Y Price Target
$15.50Price Target Upside-2.33% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Fonar News
PremiumThe Fly
Fonar trading resumes
PremiumCompany Announcements
Fonar Receives Acquisition Proposal from CEO Group
PremiumCompany Announcements
Fonar CEO Proposes Acquisition to Buy Outstanding Shares
PremiumCompany Announcements
Fonar Corporation Reports Strong Earnings Growth in Q1 2025
PremiumCompany Announcements
Fonar Holds Annual Stockholders Meeting and Elections
PremiumCompany Announcements
FONAR Corporation Reports Lower Quarterly Earnings
PremiumCompany Announcements
Fonar Corporation Delays 10-Q FilingOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
12.42% Mutual Funds
0.18% Other Institutional Investors
78.80% Public Companies and
Individual Investors
FONR FAQ
What was Fonar Corp’s price range in the past 12 months?
Fonar Corp lowest stock price was $12.00 and its highest was $18.64 in the past 12 months.
What is Fonar Corp’s market cap?
Fonar Corp’s market cap is $102.35M.
When is Fonar Corp’s upcoming earnings report date?
Fonar Corp’s upcoming earnings report date is Sep 30, 2025 which is in 67 days.
How were Fonar Corp’s earnings last quarter?
Fonar Corp released its earnings results on May 15, 2025. The company reported $0.373 earnings per share for the quarter, beating the consensus estimate of N/A by $0.373.
Is Fonar Corp overvalued?
According to Wall Street analysts Fonar Corp’s price is currently Overvalued.
Does Fonar Corp pay dividends?
Fonar Corp does not currently pay dividends.
What is Fonar Corp’s EPS estimate?
Fonar Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fonar Corp have?
Fonar Corp has 6,203,465 shares outstanding.
What happened to Fonar Corp’s price movement after its last earnings report?
Fonar Corp reported an EPS of $0.373 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 10.621%.
Which hedge fund is a major shareholder of Fonar Corp?
Currently, no hedge funds are holding shares in FONR
Fonar Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.50 (-2.33% Downside)
$15.50 (-2.33% Downside)
Blogger Sentiment
Bullish
FONR Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.41%
12-Months-Change
Fundamentals
Return on Equity
5.00%
Trailing 12-Months
Asset Growth
2.52%
Trailing 12-Months
Company Description
Fonar Corp
Fonar Corporation, founded in 1978, is a U.S.-based company that operates in the healthcare sector, specifically focusing on medical imaging. It is renowned for being a pioneer in the development of MRI (Magnetic Resonance Imaging) technology. The company's core products include MRI scanners, with a specialization in upright MRI systems, which allow patients to be scanned in various positions, including weight-bearing positions. This capability is particularly beneficial for diagnosing certain conditions that may not be as apparent in traditional, supine MRI scans.
Technical Analysis
Cytosorbents
―
Xtant Medical Holdings
―
Sensus Healthcare
―
Hyperfine
―
Icecure Medical
―